1.Three-dimensional stress analysis of implant systems in the mandibular bone with various abutment types and loading conditions.
Ha Shik SHIN ; Heoung Jae CHUN ; Chong Hyun HAN ; Soo Hong LEE
The Journal of Korean Academy of Prosthodontics 2003;41(5):617-625
STATEMENT OF PROBLEM: There are many studies focused on the effect of shape of fixtures on stress distribution in the mandibular bone. However, there are no studies focused on the effect of the abutment types on stress distribution in mandibular bone. PURPOSE: The purpose of this study is to investigate the effect of three different abutment types on the stress distributions in the mandibular bone due to various loads by performing finite element analysis. Material and method : Three different implant systems produced by Warantec (Seoul, Korea) were modeled to study the effect of abutment types on the stress distribution in the mandibular bone. The three implant systems are classified into oneplant (Oneplant, OP-TH-S11.5), internal implant (Inplant, IO-S11.5) and external implant (Hexplant, EH-S11.5). All abutments were made of titanium grade ELI, and all fixtures were made of titanium grade IV. The mandibular bone used in this study is constituted of compact and spongeous bone assumed to be homogeneous, isotropic and linearly elastic. A comparative study of stress distributions in the mandibular bone with three different types of abutment was conducted. RESULTS: It was found that the types of abutments have significant influence on the stress distribution in the mandibular bone. It was due to difference in the load transfer mechanism and the size of contact area between abutment and fixture. Also the maximum effective stress in the mandibular bone was increased with the increase of inclination angle of load. CONCLUSION: It was concluded that the maximum effective stress in the bone by the internal implant was the lowest among the maximum effective stresses by other two types.
Finite Element Analysis
;
Titanium
2.Characteristics of Respiratory Tract Infection in the Hematopoietic Stem Cell Transplantation Population.
Dong Gun LEE ; Sang Tae PARK ; Byoung Kuk NA ; Jung Hyun CHOI ; Wan Shik SHIN ; Soon Young PAIK ; Ju Mi SHIN ; Chun KANG ; Woo Joo KIM ; Hoan Jong LEE ; Chun Choo KIM
Korean Journal of Infectious Diseases 2001;33(6):419-429
PURPOSES: The respiratory tract infection is one of the most prevalent and serious complications following hematopoietic stem cell transplantation (HSCT). Reports not only for the respiratory tract infection but, unlikely for bacteria or fungi, for the infections caused by the respiratory viruses have been rarely reported in Korea. During the winter of 2000~2001, authors wanted to know the prevalence rate of the respiratory tract infection and the kinds of causative microorganisms, especially the community respiratory viruses (CRV). Based on these data, we attempted to evaluate the clinical courses and prognosis of the patients. METHODS: From October 2000 to February 2001, specimens were collected from the patients who visited Catholic hemopoietic stem cell transplantation center, showing symptoms and signs of respiratory tract infection after HSCT. Standard methods have been applied to isolate and identify bacterial and fungal species. Measles was diagnosed based on the typical symptoms, rash, fever, and Koplik spot. For the four different CRV (adenovirus, RSV, influenza virus, parainfluenza virus), multiplex PCR and conventional culture method were used for the identification. RESULTS: Eighty-four specimens were collected from 66 patients for 4 month period. Average age of patients was 35+/-8 years. Sixty patients (90%) were received allogeneic HSCT. Sample collection was performed between 10 and 3,740 days (average 370 days, median 215 days) after HSCT. Forty-seven patients (71.2%) have been received immunosuppressants at the time of respiratory tract infection. Forty patients (60.6 %) were suffered lower respiratory tract infection and forty-four patients (66.7%) had community-acquired infection. Sixty microorganisms were identified from 45 patients out of total 66 patients. Identified microoganisms were bacteria accounting for 2 cases (3.4%), fungi for 11 (18.3%), tuberculosis for 5 (8.3%), and viruses for 42 (70.0%). Among viruses, 16 cases were measles (39%), 14 adenovirus (33%), 9 cytomegalovirus (21%), 2 parainfluenza virus (5%), 1 was influenza virus (2%). However, no RSV was identified. Most of patients showed good prognosis without any complications. Ten (15.2%) out of total 66 patients were expired. The direct cause of death for all 8 among 10 patients was pneumonia. CONCLUSION: Of the respiratory tract infection fol-lowing HSCT, most common causative microorganisms were viruses - measles, adenovirus in order. No case of RSV infection was found. No epidemic must be occurred by influenza virus because only 1 case was found. Fourteen patients were infected by more than one microorganisms. Overall mortality rate was 15.2%. This study is still undergoing and once accumulated data for more than 1 year, it might be possible to work out a strategies of treatment and prevention for respiratory tract infections. We also expect that these data might be able to provide the basis of efficient infection control in HSCT unit.
Adenoviridae
;
Bacteria
;
Bone Marrow Transplantation
;
Cause of Death
;
Community-Acquired Infections
;
Cytomegalovirus
;
Exanthema
;
Fever
;
Fungi
;
Hematopoietic Stem Cell Transplantation*
;
Hematopoietic Stem Cells*
;
Humans
;
Immunosuppressive Agents
;
Infection Control
;
Korea
;
Measles
;
Mortality
;
Multiplex Polymerase Chain Reaction
;
Orthomyxoviridae
;
Paramyxoviridae Infections
;
Pneumonia
;
Prevalence
;
Prognosis
;
Respiratory System*
;
Respiratory Tract Infections*
;
Stem Cell Transplantation
;
Tuberculosis
3.Prognostic Factors Influencing Infection-related Mortality in Patients with Acute Leukemia in Korea.
Jin Hong YOO ; Su Mi CHOI ; Dong Gun LEE ; Jung Hyun CHOI ; Wan Shik SHIN ; Woo Sung MIN ; Chun Choo KIM
Journal of Korean Medical Science 2005;20(1):31-35
We retrospectively reviewed the medical records of 284 patients with neutropenic fever following chemotherapy for acute leukemia at the Catholic Hematopoietic Stem Cell Transplantation Center from January 1998 to December 1999, to identify prognostic factors for infection related mortality. Twenty-eight patients died of infections. There was no difference in median age, gender ratio, or underlying disease between the dying and surviving groups. Bacteria were the main pathogens following chemotherapy, and Gram positive organisms predominated in the dying group. Pneumonia and sepsis were the main causes of death. There were 72 cases of invasive fungal infection and their mortality was 27.8%. Invasive fungal infection and previous history of fungal infection were independent prognostic factors for outcome. Recovery from neutropenia was the significant protective factor for mortality. In conclusion, the prognostic factors identified in this study could be useful for deciding on more intensive treatment for those patients at greater risk of death. To our knowledge, this is the first Korean study delineating prognostic factors in acute leukemic patients with infectious complications.
Adolescent
;
Adult
;
Aged
;
Bacterial Infections/complications/*mortality
;
Cause of Death
;
Female
;
Humans
;
Korea
;
Leukemia
;
Leukemia, Lymphocytic, Acute/complications/*microbiology/*mortality
;
Leukemia, Myelocytic, Acute/complications/*microbiology/*mortality
;
Male
;
Middle Aged
;
Morbidity
;
Multivariate Analysis
;
Mycoses/complications/mortality
;
Neutropenia
;
Pneumonia/complications/mortality
;
Prognosis
;
Retrospective Studies
;
Sepsis/complications/mortality
;
Survival Rate
4.Immunomodulatory Effects of Mesenchymal Stem Cells in a Murine Model of TNBS-Induced Colitis.
Yong Beom CHO ; Min Shik KIM ; Min Jeong KANG ; Hee Jung SHIN ; Seok Hyung KIM ; Hee Cheol KIM ; Seong Hyeon YUN ; Woo Yong LEE ; Ho Kyung CHUN
Journal of the Korean Surgical Society 2010;79(5):317-325
PURPOSE: Mesenchymal stem cells (MSCs) are surfacing as a new method of treatment for various diseases that have poor outcome with drug treatments. In this study, we investigated the effects of MSCs in a murine intestinal inflammation model mimicking human Crohn's disease (CD) using 2,4,5-trinitrobenzene sulfonic acid (TNBS). METHODS: Colitis was induced by rectal administration of 2 mg of TNBS in 35% ethanol as experimental group compared to control group. Histological changes, surface molecules of T and B cells of the spleen and blood, and cytokine production (IFN-gamma, TNF-alpha, IL-4, IL-6, IL-10, and IL-12) were determined among 3 groups comprised of control group, TNBS group and TNBS/MSC group. RESULTS: In the mice treated with MSCs, there was a decrease in the wasting disease process and inflammatory histopathological changes. There was also a decrease in pro-inflammatory T-helper 1 (Th1) cytokines IFN-gamma and IL-12 and T-helper 2 (Th2) cytokine IL-4. Anti-inflammatory cytokine IL-10 increased in mice treated with MSCs compared to colitic mice. The blood CD4+CD25+ T-regulatory cells also increased and splenic CD19 B-cells decreased. CONCLUSION: The results of this study suggest that MSCs may have a therapeutic effect in controlling the Th1 and Th2 mediated immune response in patients with CD and aid in tissue regeneration.
Administration, Rectal
;
Animals
;
B-Lymphocytes
;
Colitis
;
Crohn Disease
;
Cytokines
;
Ethanol
;
Humans
;
Inflammation
;
Inflammatory Bowel Diseases
;
Interleukin-10
;
Interleukin-12
;
Interleukin-4
;
Interleukin-6
;
Mesenchymal Stromal Cells
;
Mice
;
Regeneration
;
Spleen
;
Tumor Necrosis Factor-alpha
;
Wasting Syndrome
5.A Case of Mediastinal Tuberculous Abscess and Lymphadenitis after Bone Marrow Transplantation.
Chang Wook KIM ; Dong Jun LIM ; Theresa JANG ; Tae Seo SOHN ; Dong Gun LEE ; Mi Young KIM ; Jung Hyun CHOI ; Wan Shik SHIN ; Chun Choo KIM
Korean Journal of Infectious Diseases 1999;31(3):247-251
After bone marrow transplantation (BMT), recipients can be complicated by infectious or non-infectious chest lesions such as mycobacterial infections or post- transplant lymphoproliferative disorders (PTLDs). BMT recipients usually face a lot of risks of mycobacterial infection because they have severely impaired cell- mediated immunity as a result of their underlying disease, chemotherapy, radiotherapy, acute or chronic graft-versus-host diesase (GVHD) and their treatment. We report a case of mediastinal tuberculous abscess and lymphadenitis after BMT, which mimicks PTLDs. 20 months before admission, BMT was performed on a 41 year-old woman who was diagnosed as chronic myelocytic leukemia. She showed acute and chronic GVHD with several infections of bacteria or viruses after BMT. In endemic area of tuberculosis such as Korea, PTLDs should be differentiated from pulmonary tuberculosis and tuberculous lymphadenitis.
Abscess*
;
Adult
;
Bacteria
;
Bone Marrow Transplantation*
;
Bone Marrow*
;
Drug Therapy
;
Female
;
Humans
;
Korea
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
Lymphadenitis*
;
Lymphoproliferative Disorders
;
Radiotherapy
;
Thorax
;
Tuberculosis
;
Tuberculosis, Lymph Node
;
Tuberculosis, Pulmonary
6.Enhanced Efficacy of Human Brain-Derived Neural Stem Cells by Transplantation of Cell Aggregates in a Rat Model of Parkinson's Disease.
Eun Sil SHIN ; Onyou HWANG ; Yu Shik HWANG ; Jun Kyo Francis SUH ; Young Il CHUN ; Sang Ryong JEON
Journal of Korean Neurosurgical Society 2014;56(5):383-389
OBJECTIVE: Neural tissue transplantation has been a promising strategy for the treatment of Parkinson's disease (PD). However, transplantation has the disadvantages of low-cell survival and/or development of dyskinesia. Transplantation of cell aggregates has the potential to overcome these problems, because the cells can extend their axons into the host brain and establish synaptic connections with host neurons. In this present study, aggregates of human brain-derived neural stem cells (HB-NSC) were transplanted into a PD animal model and compared to previous report on transplantation of single-cell suspensions. METHODS: Rats received an injection of 6-OHDA into the right medial forebrain bundle to generate the PD model and followed by injections of PBS only, or HB-NSC aggregates in PBS into the ipsilateral striatum. Behavioral tests, multitracer (2-deoxy-2-[18F]-fluoro-D-glucose ([18F]-FDG) and [18F]-N-(3-fluoropropyl)-2-carbomethoxy-3-(4-iodophenyl)nortropane ([18F]-FP-CIT) microPET scans, as well as immunohistochemical (IHC) and immunofluorescent (IF) staining were conducted to evaluate the results. RESULTS: The stepping test showed significant improvement of contralateral forelimb control in the HB-NSC group from 6-10 weeks compared to the control group (p<0.05). [18F]-FP-CIT microPET at 10 weeks posttransplantation demonstrated a significant increase in uptake in the HB-NSC group compared to pretransplantation (p<0.05). In IHC and IF staining, tyrosine hydroxylase and human beta2 microglobulin (a human cell marker) positive cells were visualized at the transplant site. CONCLUSION: These results suggest that the HB-NSC aggregates can survive in the striatum and exert therapeutic effects in a PD model by secreting dopamine.
Animals
;
Axons
;
Brain
;
Cell Transplantation
;
Dopamine
;
Dyskinesias
;
Forelimb
;
Humans
;
Medial Forebrain Bundle
;
Models, Animal*
;
Neural Stem Cells*
;
Neurons
;
Oxidopamine
;
Parkinson Disease*
;
Rats
;
Suspensions
;
Tissue Transplantation
;
Transplants
;
Tyrosine 3-Monooxygenase
7.Induction of Aspergillus fumigatus Specific T Cells using Dendritic Cells Pulsed with Asp f16 Recombinant Protein in vitro.
Hee Yeun WON ; Eun Kyung KIM ; Hyun Jung SOHN ; Wan Shik SHIN ; Woo Sung MIN ; Chun Choo KIM ; Tai Gyu KIM
Journal of Bacteriology and Virology 2005;35(4):307-314
Invasive aspergillosis is the most common Aspergillus fumigatus infection in immunocompromised patients. Although the treatment of the invasive aspergillosis has been mostly relied on antifungal agents, there still exists the need for more effective therapy. To develop cellular immunotherapy specific for Aspergillus fumigatus, we generated specific T cells using dendritic cells (DCs) pulsed with an Aspergillus fumigatus derived recombinant protein in vitro and examined their functions. The f16. p2+3 region containing the conserved region of Asp f16 gene was cloned from Aspergillus fumigatus and the recombinant protein was produced in E. coli. IFN-gamma secretion from the T cells stimulated with recombinant f16. p2+3 (rf16. p2+3) was measured by enzyme linked immunospot (ELISPOT) assay and the cytolytic activity of the stimulated T cells by 51Cr release assay. The number of IFN-gamma secreting cells were significantly increased in the peripheral blood mononuclear cells (PBMCs) stimulated with the rf16. p2+3 pulsed DCs (31+/-12 spots/10(4) cells), compared to that of PBMCs directly stimulated with rf16. p2+3 (83+/-15 spots/10(6) cells). IFN-gamma ELISPOT assay using purified CD4+ or CD8+ as responder cells showed that CD4+ T cells (43 spots/10(4) cells) mainly produced IFN-gamma compared with CD8+ T cells (7 spots/10(4) cells). Furthermore, helper T cells specific for rf16. p2+3 could be efficiently generated by the stimulation with DCs for two weeks. However, cytotoxic T lymphocyte activity was not induced. Our results suggest that the rf16. p2+3 protein could be used for the generation of helper T cells in vitro.
Antifungal Agents
;
Aspergillosis
;
Aspergillus fumigatus*
;
Aspergillus*
;
Clone Cells
;
Dendritic Cells*
;
Enzyme-Linked Immunospot Assay
;
Immunocompromised Host
;
Immunotherapy
;
Lymphocytes
;
T-Lymphocytes*
;
T-Lymphocytes, Helper-Inducer
;
Viperidae*
8.Rapamycin-Induced Abundance Changes in the Proteome of Budding Yeast.
Chun Shik SHIN ; Yeon Ji CHANG ; Hun Goo LEE ; Won Ki HUH
Genomics & Informatics 2009;7(4):203-207
The target of rapamycin (TOR) signaling pathway conserved from yeast to human plays critical roles in regulation of eukaryotic cell growth. It has been shown that TOR pathway is involved in several cellular processes, including ribosome biogenesis, nutrient response, autophagy and aging. However, due to the functional diversity of TOR pathway, we do not know yet some key effectors of the pathway. To find unknown effectors of TOR signaling pathway, we took advantage of a green fluorescent protein (GFP)-tagged collection of budding yeast Saccharomyces cerevisiae . We analyzed protein abundance changes by measuring the GFP fluorescence intensity of 4156 GFP-tagged yeast strains under inhibition of TOR pathway. Our proteomic analysis argues that 83 proteins are decreased whereas 32 proteins are increased by treatment of rapamycin, a specific inhibitor of TOR complex 1 (TORC1). We found that, among the 115 proteins that show significant changes in protein abundance under rapamycin treatment, 37 proteins also show expression changes in the mRNA levels by more than 2-fold under the same condition. We suggest that the 115 proteins indentified in this study may be directly or indirectly involved in TOR signaling and can serve as candidates for further investigation of the effectors of TOR pathway.
Aging
;
Autophagy
;
Eukaryotic Cells
;
Fluorescence
;
Humans
;
Imidazoles
;
Multiprotein Complexes
;
Nitro Compounds
;
Proteins
;
Proteome
;
Ribosomes
;
RNA, Messenger
;
Saccharomyces cerevisiae
;
Saccharomycetales
;
Sirolimus
;
TOR Serine-Threonine Kinases
;
Yeasts
;
Organelle Biogenesis
9.Fucoidan attenuates 6-hydroxydopamine-induced neurotoxicity by exerting anti-oxidative and anti-apoptotic actions in SH-SY5Y cells.
Myung Hwan KIM ; Hoon NAMGOONG ; Bae Dong JUNG ; Myung Sang KWON ; Yeon Shik CHOI ; Taekyun SHIN ; Hyoung Chun KIM ; Myung Bok WIE
Korean Journal of Veterinary Research 2017;57(1):1-7
Parkinson's disease (PD) is an irreversible neurological disorder with related locomotor dysfunction and is haracterized by the selective loss of nigral neurons. PD can be experimentally induced by 6-hydroxydopamine (6-OHDA). It has been reported that reactive oxygen species, which deplete endogenous glutathione (GSH) levels, may play important roles in the dopaminergic cell death characteristic of PD. Fucoidan, a sulfated algal polysaccharide, exhibits anti-inflammatory and anti-oxidant actions. In this study, we investigated whether fucoidan can protect against 6-OHDA-mediated cytotoxicity in SH-SY5Y cells. Cytotoxicity was evaluated by using MTT and LDH assays. Fucoidan alleviated cell damage evoked by 6-OHDA dose-dependently. Fucoidan reduced the number of apoptotic nuclei and the extent of annexin-V-associated apoptosis, as revealed by DAPI staining and flow cytometry. Elevation of lipid peroxidation and caspase-3/7 activities induced by 6-OHDA was attenuated by fucoidan, which also protected against cytotoxicity evoked by buthionine-sulfoximine-mediated GSH depletion. Reduction in the glutathione/glutathione disulfide ratio induced by 6-OHDA was reversed by fucoidan, which also inhibited 6-OHDA-induced disruption of mitochondrial membrane potential. The results indicate that fucoidan may have protective action against 6-OHDA-mediated neurotoxicity by modulating oxidative injury and apoptosis through GSH depletion.
Apoptosis
;
Cell Death
;
Flow Cytometry
;
Glutathione
;
Lipid Peroxidation
;
Membrane Potential, Mitochondrial
;
Nervous System Diseases
;
Neurons
;
Oxidopamine
;
Parkinson Disease
;
Reactive Oxygen Species
10.Selective bowel decontamination for the prevention of infection in acute myelogenous leukemia: A prospective randomized trial.
Dong Gun LEE ; Jung Min YOON ; Jae Hyoung CHO ; Su Mi CHOI ; Yoon Hee PARK ; Yoo Jin KIM ; Seok LEE ; Jung Hyun CHOI ; Jong Wook LEE ; Wan Shik SHIN ; Chun Choo KIM
Korean Journal of Medicine 2001;60(2):167-174
BACKGROUND: Infections are still a frequent cause of morbidity and mortality in patients with hematologic malignancies. Antimicrobial prophylaxis in neutropenic patients has been practised for several decades. But, recently the rates of occurrence for pathogens have significantly changed (from predominance of gram-negative to gram-positive species) under selective pressure of antimicrobial prophylaxis, and novel resistance mechanisms have emerged. We investigated this study to assess the effectiveness of selective bowel decontamination for preventing infections in granulocytopenic patients who are receiving chemotherapy for acute myelogenous leukemia. METHODS: In a prospective, randomized trial, we evaluated the efficacy of oral ciprofloxacin (250 mg p.o. twice a day), roxithromycin (150 mg p.o. twice a day), fluconazole (50 mg p.o.) in 95 adult patients with acute myelogenous leukemia who undergone intensive chemotherapy. Prophylaxis was begun within 72 hours of initiation of the chemotherapy and continued until the onset of fever, signs or symptoms of infection, serious adverse effect, or recovery of the leukocyte count to > or = 1,000/mm3. RESULTS: 46 decontamination regimen treated patients and 49 control patients were assessable for efficacy. No difference was noted between the two groups in occurrence of fever during neutropenia, time to onset of first fever, sites of infection, duration of using systemic antimicrobials, overall infection rates, infection-related mortality, or hospitalization day. Decontamination regimen reduced the gram-negative infections, but increased the gram-positive infections. Among those who received decontamination regimen, the incidence of resistance to ciprofloxacin was 100% for gram-negative species. And resistance to erythromycin for gram-positive species, irrespective of decontamination, was very much high (90-100%). CONCLUSION: The approach of selective decontamination has not led to fewer febrile episodes or to a lower mortality in neutropenia after chemotherapy for acute myelogenous leukemia. It should be considered that we had better not prescribe decontamination regimen because of increment of infection due to gram-positive species and high resistance rate to fluoroquinolone and macrolide. Additional trials are needed to establish the efficacy of decontamination for other malignancies, aplastic anemia, or bone marrow transplantation.
Adult
;
Anemia, Aplastic
;
Bone Marrow Transplantation
;
Ciprofloxacin
;
Decontamination*
;
Drug Therapy
;
Erythromycin
;
Fever
;
Fluconazole
;
Hematologic Neoplasms
;
Hospitalization
;
Humans
;
Incidence
;
Leukemia
;
Leukemia, Myeloid, Acute*
;
Leukocyte Count
;
Mortality
;
Neutropenia
;
Prospective Studies*
;
Roxithromycin